It has been about a month since the last earnings report for Pfizer (PFE). Shares have lost about 9.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 ...

Is the healthcare stock in big trouble and headed for a greater decline, or are investors perhaps a bit too bearish on the ...

A new pharmaceutical storage facility is coming to Wilmington International Airport’s Business Park, airport officials said ...

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In this article, we are going to ...

Amazon Web Services Inc. is betting big on artificial intelligence as it scrambles to gain mindshare from perceived leaders ...

See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.77 which represents a decrease of $-0.40 or -1.53% from the prior close of $26.17. The stock opened at $26.16 and touched a low ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that members of its executive leadership team will present and host investor meetings at several upcoming conferences. **Details on the ...

Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer ...

You can now purchase a test that will tell you whether you are sick with COVID or the flu -- no prescription required.